Amplio Pharma BV

Amplio Pharma BV is an innovative pharmaceutical company dedicated to developing improved versions of established drugs. Focused on applying cutting-edge technology to address the shortcomings of existing treatments, Amplio Pharma is committed to enhancing patient outcomes and transforming the pharmaceutical landscape.

With a vision to improve the effectiveness of proven therapies, Amplio Pharma BV is pioneering advancements in drug delivery and optimization. Their lead development candidate, NovoBioJect (AMP101), aims to significantly boost the responder rate to the current first-line Rheumatoid Arthritis (RA) treatment. Amplio Pharma’s inverse retention technology platform is designed to maintain the active form of injectable low-dose methotrexate in the body for an extended period, potentially increasing the responder rate from approximately 35% to up to 70%.

Located in Amsterdam, at Amsterdam, 1032 LB, NL, Amplio Pharma is poised to make a substantial impact on the pharmaceutical industry through its innovative approaches and dedication to improving patient care. We invite the manager of Amplio Pharma BV to create a customized and exclusive company showcase and product listing on our platform to further highlight their advancements and commercial potential.